Katherine Murray - May 19, 2022 Form 3 Insider Report for CORE LABORATORIES N V (CLB)

Role
Director
Signature
/s/ Mark D. Tattoli, Attorney-in-fact
Stock symbol
CLB
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
3
Date filed
5/27/2022, 04:57 PM
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLB Common Shares 0 May 19, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLB Restricted Shares May 19, 2022 Common Shares 5.49K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares were granted to Ms. Murray upon her election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2022, and will vest, without performance criteria, on April 1, 2023, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.